Ventura BioMed Investors
Venture capitalMunich · Seed–Series A · 2 people tracked
Find your way into Ventura BioMed Investors
Investment thesis
Ventura BioMed Investors focuses on early-stage life science companies developing pioneering technologies and innovative therapies. It typically invests EUR 1-5 million per company, always co-investing in consortia with other funds and within Europe. The firm can further expand its reach through Ventura Ace, an investment platform of selected private investors. Led by serial biotech and pharmaceutical entrepreneurs, the firm helps shape the long-term development of its portfolio companies and provides them with access to a broad investor and business network to accelerate medical breakthroughs.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 5 of 6 portfolio companiesBiotech ×5Healthtech ×3Medical Devices ×3Deep Tech ×2AI & Machine Learning ×1Digital Health ×1
HQs:Germany×3United States×1
Investments · 6 tracked
founders shown can be your intro path
Kupando is a biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases.
AI & Machine LearningBiotechMedical DevicesSchönefeld, DE
Johanna Holldack(CEO)in
BoardPierre Morgon(Chairman)Wolfram Nothaft(Deputy Chairman)
Co-investorsBrandenburg KapitalRemiges Ventures, Inc.
Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer.
BiotechHealthtech
Co-investorsBoehringer Ingelheim Venture Fund
Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics.
BiotechDeep TechMedical Devices
iQure Pharma is a clinical-stage biotech developing astrocyte-targeted therapeutics that enhance EAAT2 to restore glutamate balance in central nervous system disorders such as epilepsy, Parkinson's disease, migraine, and ALS.
BiotechHealthtechSkillman, US
Peter Schiemann(Founder)inPawel Zolnierczyk(Executive Officer)in
Co-investorsKeiretsu Forum
TQ Therapeutics develops cell and gene therapy technologies and processes to make challenging diseases curable.
BiotechDeep TechDigital HealthHealthtechMedical DevicesPlanegg, DE
Dr. Christian Eckert(Chief Executive Officer & Co-Founder)Dr. Christian Stemberger(Chief Scientific Officer & Co-Founder)Sabine Radisch(Chief Technology Officer & Co-Founder)inDr. Stefan Dreher(Chief Operating Officer & Co-Founder)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Kupando
Portfolio news
latest coverage across their companiesarcoris bio · startupsmagazine.co.uk · Nov 7, 2025
iQure Pharma · geneonline.com · Sep 29, 2025
Frequently asked questions
- How many investments has Ventura BioMed Investors made?
- Ventura BioMed Investors has 6 tracked investments.
- What stage does Ventura BioMed Investors invest at?
- Ventura BioMed Investors invests at the Seed, Series A stages.
- What is Ventura BioMed Investors's typical check size?
- Ventura BioMed Investors typically writes checks of $1.1M – $5.5M.
- What sectors does Ventura BioMed Investors focus on?
- Ventura BioMed Investors focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Ventura BioMed Investors located?
- Ventura BioMed Investors is headquartered in Munich, DE.
- Does Ventura BioMed Investors lead rounds?
- Ventura BioMed Investors typically participates in rounds rather than leading them.
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Wavemaker 360 is a healthcare-focused venture capital firm that backs entrepreneurs building disruptive companies transforming the healthcare industry. Its limited partners are largely individuals with significant healthcare industry experience.
HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.
Next Ventures is an investment firm that backs founders building solutions to improve health care access and enhance human capability.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.